PROM1 and prostate carcinoma: CD133 (human prominin-1), a kind of glycoprotein with five transmembrane regions, has been identified as a valid CSC marker in gastrointestinal cancers including gastric, liver, colorectal, pancreatic cancers (106–109) and other cancers like lung (110), brain (10), and prostate cancers (16).